Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma

N. Kathiravetpillai, M. Koeter, M. J. C. van der Sangen, G. J. Creemers, M. D. P. Luyer, H. J. T. Rutten, G. A. P. Nieuwenhuijzen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1183-1190
JournalEuropean Journal of Surgical Oncology
Issue number8
Publication statusPublished - Aug 2016


  • Oesophageal adenocarcinoma
  • Neoadjuvant chemoradiotherapy
  • Interval
  • Postoperative outcome

Cite this